Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment

Keyphrases

• Age-related 100%
• Clinical Approach 100%
• Factor XI Deficiency 100%
• Bleeding Risk Score 100%
• Phenotypic Age 100%
• Bleeding Risk 50%
• Bleeding Complications 50%
• Laboratory Assays 50%
• Rare Bleeding Disorders 50%
• Plasma Parameters 25%
• Activity Level 25%
• Genotype 25%
• Treatment Strategy 25%
• Neonate 25%
• Bleeding 25%
• Moderate to Severe 25%
• Patient Assessment 25%
• Treatment Options 25%
• Between-person 25%
• Clinical Manifestations 25%
• Older Patients 25%
• Bleeding Tendency 25%
• Bleeding Symptoms 25%
• Treatment Decisions 25%
• Surgical Factors 25%
• Postpartum Hemorrhage 25%
• Specific Group 25%
• Risk Management 25%
• Thrombotic Complications 25%
• Bleeding Profile 25%
• Diagnostic Laboratory 25%
• Diagnostic Approach 25%
• Surgical Site 25%
• Replacement Product 25%
• Complex Challenges 25%
• Assessment Risk 25%
• Global Assays 25%
• Abnormal Uterine Bleeding 25%
• Reproductive Age 25%
• Antifibrinolytics 25%
• Nonreplacement Therapy 25%
• Recombinant Activated FVII 25%
• Perioperative Assessment 25%

Medicine and Dentistry

• Medical Decision Making 100%
• Factor XI 100%
• Bleeding 71%
• Diagnosis 28%
• Bleeding Disorder 28%
• Symptom 14%
• Decision Making 14%
• Lifespan 14%
• Bleeding Diathesis 14%
• Neonate 14%
• Surgical Site 14%
• Lochia 14%
• Uterus Bleeding 14%
• Antifibrinolytic 14%
• Patient Assessment 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Blood Clotting Factor 11 100%
• Bleeding 71%
• Bleeding Disorder 28%
• Symptom 14%
• Bleeding Tendency 14%
• Postpartum Hemorrhage 14%
• Uterus Bleeding 14%
• Antifibrinolytic Agent 14%